Bilanafos

• CAT Number: I023391
• CAS Number: 35597-43-4
• Molecular Formula: C11H22N3O6P
• Molecular Weight: 323.28
• Purity: ≥95%
• Synonyms: Bilanafos; Bialaphos; Herby; Antibiotic SF 1293
• Target: Bacterial
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
• IUPAC Name: (2-amino-4-((hydroxymethyl)hydrophosphoryl)butanoyl)-L-alanyl-L-alanine
• InChI: InChI=1S/C11H22N3O6P/c1-6(9(16)14-7(2)11(18)19)13-10(17)8(12)3-4-21(20)5-15/h6-8,15,21H,3-5,12H2,1-2H3,(H,13,17)(H,14,16)(H,18,19)/t6-,7-,8?/m0/s1
• InChIKey: VGEZOZJJXPKDEJ-WPZUCAASSA-N
• SMILES: C[C@@H](C(O)=O)NC([C@H](C)NC(C(N)CCP(CO)=O)=O)=O

Bilanafos (Cat.No:I023391) is an antifungal agent used in agriculture to control fungal infections in crops. It works by inhibiting the activity of the fungal enzyme squalene epoxidase, which is essential for the biosynthesis of ergosterol, a component of fungal cell membranes. Bilanafos has shown efficacy against a range of fungal pathogens and is used in the protection of crops such as rice, wheat, and barley.

Reference

1: Bilanakis N, Vratsista A, Siorou S. A brain ependymoma with psychiatric manifestation. J BUON. 2017 Nov-Dec;22(6):1604-1605. PubMed PMID: 29332363.
2: Bilanakis N, Peritogiannis VK, Vratsista A. Treatment decision-making capacity in hospitalized patients with schizophrenia. Psychiatriki. 2017 Jan-Mar;28(1):37-45. doi: 10.22365/jpsych.2017.281.37. PubMed PMID: 28541237.
3: Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A. Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opin Pharmacother. 2016 Jun;17(8):1043-53. doi: 10.1080/14656566.2016.1174692. Epub 2016 May 9. PubMed PMID: 27042990; PubMed Central PMCID: PMC4898156.
4: Bilanakis N, Vratsista A, Athanasiou E, Niakas D, Peritogiannis V. Medical patients’ treatment decision making capacity: a report from a general hospital in Greece. Clin Pract Epidemiol Ment Health. 2014 Nov 26;10:133-9. doi: 10.2174/1745017901410010133. eCollection 2014. PubMed PMID: 25505489; PubMed Central PMCID: PMC4260233.
5: Bilanakis N, Vratsista A, Kalampokis G, Papamichael G, Peritogiannis V. The Greek version of the MacArthur competence assessment tool for treatment: reliability and validity. Evaluation of capacity for treatment decisions in Greek psychiatric patients. Ann Gen Psychiatry. 2013 Apr 9;12(1):10. doi: 10.1186/1744-859X-12-10. PubMed PMID: 23570333; PubMed Central PMCID: PMC3648422.
6: Bilanakis N. [Compulsory hospitalization: α case of conflict between the psychiatrist and the persecutor due to the obscurity of the law]. Psychiatriki. 2012 Jul-Sep;23(3):255-61. Greek, Modern. PubMed PMID: 23073548.
7: Bilanakis N, Papamichael G, Peritogiannis V. Chemical restraint in routine clinical practice: a report from a general hospital psychiatric ward in Greece. Ann Gen Psychiatry. 2011 Feb 24;10:4. doi: 10.1186/1744-859X-10-4. PubMed PMID: 21349171; PubMed Central PMCID: PMC3050779.
8: Bilanakis N, Kalampokis G, Christou K, Peritogiannis V. Use of coercive physical measures in a psychiatric ward of a general hospital in Greece. Int J Soc Psychiatry. 2010 Jul;56(4):402-11. doi: 10.1177/0020764009106620. Epub 2009 Jul 23. PubMed PMID: 19628555.
9: Bilanakis N, Peritogiannis V. Attitudes of patients and families toward restraint and seclusion. Psychiatr Serv. 2008 Oct;59(10):1220. doi: 10.1176/appi.ps.59.10.1220. PubMed PMID: 18832516.
10: Bilanakis N, Peritogiannis V, Kalampokis G. Infections as complications of neuroleptic malignant syndrome. World J Biol Psychiatry. 2009;10(4 Pt 3):973-6. doi: 10.1080/15622970801935578. PubMed PMID: 18609425.
11: Geitona M, Ollandezos M, Kousoulakou C, Agelopoulos E, Zaharakis K, Kakavas P, Karpouza B, Kesidou S, Bilanakis N, Papamichael E, Papanicolaou S, Chaidemenos A, Chamogeorgakis T, Kyriopoulos J. [The cost of treating schizophrenia in Greece]. Psychiatriki. 2007 Jan;18(1):47-58. Greek, Modern. PubMed PMID: 22466429.
12: Bilanakis N. Psychogenic urinary retention. Gen Hosp Psychiatry. 2006 May-Jun;28(3):259-61. PubMed PMID: 16675372.
13: Bilanakis N, Gibiriti M. Lithium intoxication, hypercalcemia and “accidentally” induced food and water aversion: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):201-3. PubMed PMID: 14687875.
14: Bilanakis N, Madianos MG, Liakos A. Psychiatric morbidity among repatriated Greek migrants in a rural area. Eur Arch Psychiatry Clin Neurosci. 1995;245(1):36-44. PubMed PMID: 7786910.